Buy FOXO4-DRI Peptide 99% Pure

Selective Senescent Cell Clearance:The peptide exhibits potent senolytic activity by targeting the FOXO4-p53 axis, a key regulator of cell aging and the aging process. Disrupting the FOXO4-p53 interaction induces p53 nuclear exclusion, leading to apoptosis in senescent cells while sparing healthy ones.

This selective clearance reduces the accumulation of senescent cells, restores tissue homeostasis, and supports cell cycle regulation. Additionally, FOXO4-DRI influences antioxidant enzymes such as manganese superoxide dismutase and glutathione peroxidase, further mitigating oxidative stress and promoting cellular health. These combined effects position FOXO4-DRI as a promising therapeutic strategy for combating age-related diseases and dysfunction (1).

Cancer Research: The peptide shows significant potential as a tumor suppressor in cancer therapy by targeting and eliminating senescent cancer cells, which often arise from DNA damage and contribute to cancer progression and recurrence. By disrupting the FOXO4-p53 interaction, it induces p53-mediated apoptosis, effectively clearing these damaged, senescent cells.

Scientific studies reveal that FOXO4-DRI enhances cell death in senescent cancer cells and improves survival in mouse melanoma models when combined with a BRAF inhibitor (2). This senolytic approach, addressing DNA damage-induced senescence, offers a promising strategy for eradicating residual disease and improving cancer treatment outcomes.

Neurodegeneration and Cognitive Function Research:Research shows it has potential in combating neurodegeneration and cognitive decline by targeting senescent cells, a key driver of age-related diseases like Alzheimer’s. By disrupting FOXO4-p53 interactions, it promotes apoptosis in senescent cells, reducing inflammation and improving cellular health (3).

Studies have demonstrated that FOXO proteins, including FOXO4, regulate oxidative stress responses and mitochondrial function, which are critical in neurological disorders. Senolytic therapies like FOXO4-DRI may offer a promising approach to modulate aging and halt neurodegenerative disease progression (4). Further research is needed to assess safety, dosage, and potential side effects.

Wound Healing and Regeneration: FOXO4-DRI’s senolytic action reduces senescent cell burden in chronic wounds, improving healing outcomes and preventing excessive fibrosis. In keloids, it disrupts the FOXO4-p53 interaction, inducing apoptosis in senescent fibroblasts and reducing pro-inflammatory and mesenchymal fibroblast subpopulations. This alleviates the persistent senescent microenvironment that drives keloid aggressiveness and recurrence (5). These findings highlight its potential in regenerative medicine and scar management.

Reproductive Health: FOXO4-DRI shows promise in improving reproductive health by targeting senescent Leydig cells, which contribute to age-related hypogonadism and reduced fertility. Studies reveal that the peptide disrupts the FOXO4-p53 interaction, inducing apoptosis in senescent Leydig cells and restoring testicular homeostasis (6).

In aged mice, it improved testosterone levels, sperm quality, and spermatogenesis by enhancing the testicular microenvironment (7). These findings highlight the peptide’s therapeutic potential for addressing male late-onset hypogonadism and age-related fertility decline.

New Hair Growth: Research indicates FOXO4-DRI promotes hair growth by targeting senescent cells that impair tissue function and follicular health. By disrupting the FOXO4-p53 interaction, it induces apoptosis in senescent cells, restoring tissue homeostasis.

Studies show it improved fur density in aged mice, highlighting its potential to rejuvenate hair follicles and combat age-related hair loss. This senolytic approach offers a promising therapeutic strategy for restoring hair growth and overall scalp health in aging individuals (8).

Metabolism and Insulin Resistance: Research has shown that the peptide influences insulin signaling and metabolism by mediating insulin’s inhibitory effects on key cellular functions like metabolism, growth, and oxidative stress. Dysregulation of FoxO proteins, including FoxO4, is linked to metabolic diseases such as insulin resistance and type 2 diabetes. By modulating pathways involved in glucose and lipid metabolism, this peptide holds potential as a therapeutic target for improving metabolic health and combating diabetes (9).